Omeros receives $126M in sale of drug franchise to British eye care company
December 30, 2021 at 17:11 PM EST
With royalties and a commercial milestone payment, Omeros says the deal is worth over $1 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|